ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SHARON GILBERT N.P.

445 PORTERFIELD HWY SW SUITE A

Abingdon | Virginia | 24210

(276) 628-3144

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 459

$354K Total Retail Price of All Prescriptions

Rank: 48 out of 459

364 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 4,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 386 251 1 5
SIMVASTATIN 373 220 2 1
OMEPRAZOLE 347 172 3 3
HYDROCODONE-ACETAMINOPHEN 323 146 S3 4 2
FUROSEMIDE 220 151 5 8
AMLODIPINE BESYLATE 210 143 6 6
METFORMIN HCL 182 106 7 7
LISINOPRIL 169 104 8 4
METOPROLOL TARTRATE 166 93 9 11
HYDROCHLOROTHIAZIDE 133 66 10 9
ATENOLOL 127 114 11 14
GABAPENTIN 125 40 12 10
CITALOPRAM HBR 108 55 13 18
TRAMADOL HCL 104 46 14 13
PRAVASTATIN SODIUM 103 56 15 12
ATORVASTATIN CALCIUM 93 67 16 15
ZOLPIDEM TARTRATE 92 13 17 19
POTASSIUM CHLORIDE 91 54 18 24
PROAIR HFA 84 16 19 32
FLUTICASONE PROPIONATE 78 18 20 36
LOSARTAN POTASSIUM 75 46 21 22
NEXIUM 74 20 22 16
CEFUROXIME 68 38 23 175
FLUCONAZOLE 65 13 24 147
NAPROXEN 63 25 25 104
SERTRALINE HCL 61 35 26 20
PROMETHAZINE HCL 59 0 R 27 86
RAMIPRIL 55 40 28 120
SPIRIVA 55 23 28 45
AMITRIPTYLINE HCL 54 22 R 30 44
ESCITALOPRAM OXALATE 54 16 30 61
WARFARIN SODIUM 54 20 30 17
CIPROFLOXACIN HCL 54 33 30 50
TAMSULOSIN HCL 54 24 30 33
ESTRADIOL 53 31 R 35 207
TIZANIDINE HCL 51 0 36 76
CYCLOBENZAPRINE HCL 51 12 R 36 41
CYMBALTA 50 26 38 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.